FDA approves Merck's combo diabetes drug

04/1/2007 | Bloomberg

The FDA approved Merck's diabetes treatment Janumet, a combination of its diabetes drug Januvia, which was approved just last year, and the older drug metformin. Janumet is the first pill to treat Type 2 diabetes by targeting all causes of the disease. Analysts expect Janumet and Januvia to bring in more than $2 billion in annual sales for Merck.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ